This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Erythrocin (Erythromycin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (11)
Death (8)
Reports by Reaction Type
Pancreatitis Acute (3),
Disseminated Intravascular Coagulation (3),
Arrhythmia (3),
Respiratory Failure (3),
Cardiac Arrest (3),
Acidosis (2),
COR Pulmonale (2),
Chest Pain (2),
Electrolyte Imbalance (2),
Anuria (2),
Pancreatic Abscess (2),
Uterine Cancer (2)
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-07
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Angioedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Erythrocin
Other drugs received by patient: Metoprolol Tartrate; Amlodipine; Zolpidem
Possible Erythrocin side effects in 41 year old male
Reported by a pharmacist from United Kingdom on 2012-07-18
Patient: 41 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Pancreatic Abscess, Pancreatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Erythrocin
Indication: Gastrointestinal Infection
Start date: 2012-04-08
Clarithromycin
Indication: Pneumonia
Start date: 2012-04-04
Other drugs received by patient: Omeprazole; Pabrinex; Tramadol HCL; Gentamicin; Norepinephrine Bitartrate; Albuterol Sulate; Acetaminophen; Alfentanil; Aminophyllin; TPN; Propofol; Insulin; Amoxicillin and Clavulanate Potassium
Possible Erythrocin side effects in 41 year old male
Reported by a pharmacist from United Kingdom on 2012-07-16
Patient: 41 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Pancreatic Abscess, Pancreatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Erythrocin
Indication: Gastrointestinal Infection
Start date: 2012-04-08
Clarithromycin
Indication: Pneumonia
Start date: 2012-04-04
Other drugs received by patient: Norepinephrine Bitartrate; Amoxicillin and Clavulanate Potassium; Pabrinex; Omeprazole; Alfentanil; Tramadol HCL; Propofol; Insulin; Albuterol Sulate; Acetaminophen; Gentamicin; Aminophyllin; TPN
Possible Erythrocin side effects in male
Reported by a consumer/non-health professional from Japan on 2012-05-17
Patient: male
Reactions: Dyspnoea, Tachycardia, Arrhythmia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Theophylline
Dosage: df
Indication: Product Used FOR Unknown Indication
Erythrocin
Dosage: df
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Sitagliptin Phosphate Monohydrate; Telmisartan and Hydrochlorothiazide; Zolpidem Tartrate; Rabeprazole Sodium; Acetaminophen
Possible Erythrocin side effects in 72 year old male
Reported by a physician from Japan on 2012-04-03
Patient: 72 year old male, weighing 69.0 kg (151.8 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Panitumumab
Dosage: 400 mg, q2wk
Indication: Colorectal Cancer
Start date: 2011-09-15
End date: 2011-09-15
Meropenem
Dosage: 1000 mg, unk
Indication: Interstitial Lung Disease
Start date: 2011-09-26
Erythrocin
Dosage: 1500 mg, unk
Start date: 2011-09-26
End date: 2011-09-30
Vancomycin
Dosage: 1000 mg, unk
Start date: 2011-10-04
End date: 2011-10-06
Minocycline Hydrochloride
Dosage: 100 mg, bid
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-09-16
End date: 2011-09-25
Erbitux
Dosage: 350 mg, unk
Indication: Colorectal Cancer
Start date: 2011-08-17
End date: 2011-08-17
Other drugs received by patient: Levoleucovorin Calcium; Fluorouracil; Fluorouracil; Hydrocortisone Sodium Succinate; Levoleucovorin Calcium; Dexamethasone Sodium Phosphate; Pydoxal; Magmitt; Oxaliplatin; Fluorouracil; Fluorouracil; Levoleucovorin Calcium; Levoleucovorin Calcium; Levoleucovorin Calcium; Rabeprazole Sodium; Fluorouracil; Warfarin Sodium; Zopicool
Possible Erythrocin side effects in
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient:
Reactions: Drug Hypersensitivity
Drug(s) suspected as cause:
Amiodarone HCL
Dosage: unk
Eplerenone
Dosage: unk
Inspra
Dosage: unk
Erythromycin
Dosage: unk
Erythromycin Stearate
Dosage: unk
Erythrocin
Dosage: unk
Amiodarone HCL
Dosage: unk
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-08
Patient: female, weighing 25.7 kg (56.5 pounds)
Reactions: Pancreatitis Acute, Respiratory Failure, Disseminated Intravascular Coagulation, Acidosis, Cardiac Arrest, Blood Pressure Decreased, Anuria
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Dosage: see image
Indication: Pneumonia
Start date: 2010-03-01
End date: 2010-04-06
Amphotericin B
Dosage: see image
Indication: Pneumonia
Start date: 2010-04-07
End date: 2010-04-12
Erythrocin
Dosage: ([2 in 1 day, after breakfast and supper (200 mg, 2 in 1 day, after breakfast and supper)] oral)
Administration route: Oral
Indication: Primary Ciliary Dyskinesia
Start date: 2005-01-01
End date: 2010-04-12
Other drugs received by patient: Midazolam; Clobazam; Tazobactam; Gabapentin; Natural Aluminum Silicate; Monoammonium; Valproate Sodium; Carbocisteine Lysine; Budesonide; Teicoplanin; Clonidine HCL; Antibiotics-Resistant Lactic Acid Bacteriae; Albumin Tannate; Minocycline Hydrochloride; Phenobarbital TAB; Ambroxol Hydrochloride; Doripenem Monohydrate; Ethyl Loflazepate; Pranlukast; Sodium Bromide
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-23
Patient: female, weighing 25.7 kg (56.5 pounds)
Reactions: Pancreatitis Acute, Vomiting, Disseminated Intravascular Coagulation, Acidosis, Heart Rate Decreased, Respiratory Failure, Abdominal Distension, Cardiac Arrest, Blood Pressure Decreased, Anuria
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
Indication: Pneumonia
Start date: 2010-03-01
Amphotericin B
Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
Indication: Pneumonia
Start date: 2010-04-07
End date: 2010-04-12
Erythrocin
Dosage: (200 mg bid oral)
Administration route: Oral
Indication: Primary Ciliary Dyskinesia
End date: 2010-04-12
Other drugs received by patient: Carbocisteine Lysine; Ambroxol Hydrochloride; Monoammonium Glycyrrhizinate; Gabapentin; Doripenem Monohydrate; Teicoplanin; Clobazam; Ethyl Loflazepate; Albumin Tannate; Antibiotics-Resistant Lactic Acid Bacteriae; Valproate Sodium; Minocycline Hydrochloride; Budesonide; Tazobactam; Phenobarbital TAB; Pranlukast; Sodium Bromide; Clonidine Hydrochloride; Natural Aluminum Silicate
Possible Erythrocin side effects in 6 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-27
Patient: 6 year old female
Reactions: Pancreatitis Acute, Disseminated Intravascular Coagulation
Adverse event resulted in: death
Drug(s) suspected as cause:
Erythrocin
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-19
Patient: female, weighing 27.5 kg (60.5 pounds)
Reactions: Unresponsive To Stimuli, Hypercapnia, Chronic Respiratory Failure, Pulmonary Granuloma, Cardiac Disorder, Pco2 Increased, Disease Progression, Lung Abscess, COR Pulmonale, Chest Pain, Electrolyte Imbalance, Bronchiolitis, Blood Pressure Diastolic Decreased, Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Ventricular Tachycardia, Respiratory Arrest, Depressed Level of Consciousness, Arteriosclerosis Coronary Artery, Cardiac Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Erythrocin
Dosage: 600 mg, (200 mg, 3 in 1 d) oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 1992-01-01
End date: 2006-06-29
Disopyramide
Dosage: 300 mg, (100 mg, 3 in 1 d), oral
Administration route: Oral
Indication: Supraventricular Tachycardia
End date: 2006-10-10
Clarithromycin
Dosage: 200 mg, 600 mg (200 mg, 3 in 1 d) oral (400 mg (200 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-06-30
End date: 2006-09-18
Clarithromycin
Dosage: 200 mg, 600 mg (200 mg, 3 in 1 d) oral (400 mg (200 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-09-19
End date: 2006-10-16
Acardi (Acardi) (Not Specified)
Dosage: 5 mg, 5 mg (2.5 mg 2 in 1 d), oral
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2006-10-16
Other drugs received by patient: Theophylline; Furosemide; Ursodiol; Zolpidem Tartrate; Rabeprazole Sodium; Radiotherapy; Tiotropium Bromide Monohydrate; Isosorbide Dinitrate
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-13
Patient: female, weighing 27.5 kg (60.5 pounds)
Reactions: Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Respiratory Failure, Ventricular Tachycardia, Chest Pain, COR Pulmonale, Respiratory Arrest, Depressed Level of Consciousness, Electrolyte Imbalance, Obstructive Airways Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Clarithromycin
Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-06-30
End date: 2006-09-18
Clarithromycin
Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-09-19
End date: 2006-10-16
Rythmodan / 00271801 / (Rythmodan) (Not Specified)
Dosage: (300 mg, 300 mg (100 mg, 3 in 1 d) oral)
Administration route: Oral
Indication: Supraventricular Tachycardia
End date: 2006-10-16
Acardi (Acardi) (Not Specified)
Dosage: (5 mg, 5 mg ( 2.5 mg, 2 in 1 d) oral)
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2006-10-16
Erythrocin
Dosage: (600 mg, 600 mg (200 mg, 3 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 1992-01-01
End date: 2006-06-29
Other drugs received by patient: Zolpidem Tartrate; Rabeprazole Sodium; Furosemide; Isosorbide Dinitrate; Radiotherapy; Theophylline; Ursodiol; Tiotropium Bromid Monohydrate
|